Myth: Deeper is better

Some TMS therapies claim deeper, more diffuse treatment that stimulates wider areas of the brain offers a better chance for improved outcomes. But there’s no published evidence demonstrating any meaningful clinical result with this type of treatment. However, studies do indicate that deeper, more diffuse treatments may be associated with increased risk of seizures and other side effects.20

Before committing to a less-precise “deep TMS” approach, take a closer look at the data comparing it to NeuroStar Advanced Therapy’s targeted, focused approach. Then consider if “deep TMS” is worth experimenting on your patients’ well-being or your practice’s future.

NeuroStar precisely targets mood-regulating brain tissue associated with depression.

Myth: All TMS systems have similar clinical results

Generic TMS systems suggest their systems are safe and effective based on clinical evidence. What they don’t say is their FDA clearance is based on NeuroStar data — not their own. They were only required to demonstrate technological similarities without having to provide the same precision-based features of NeuroStar. And none has shown safety and efficacy in substantive clinical trials.

NeuroStar Advanced Therapy is backed by the largest clinical data set of any TMS system.

Our system has been widely researched with clinical data in more than 900 patients over 11 studies—resulting in a total of 23 publications.1

Myth: All TMS therapies are the same

It’s true all TMS technologies share foundational components that deliver magnetic pulses to stimulate brain regions. But that’s where the similarities end.

Consider how other TMS systems deliver magnetic pulses that impact your patients’ chances for achieving remission. Some deliver deep and diffuse treatments that could have undesirable side effects. Some lack the ability to measure magnetic field strength, which hampers your ability to manage under/over-stimulation. Some lack patient-position sensing that monitors head movement to ensure treatment accuracy. And some lack design features that protect the device from the rigor of daily clinical use so your investment is protected.

Before choosing a TMS system for your practice, consider how their delivery system will impact your patients’ chances for recovery, and your practice’s ability to grow with TMS therapy. Only NeuroStar meticulously designed every step of treatment to ensure your patients are given the best therapy with the most precision available.

And only NeuroStar invests in providing clinical and safety benefits, comprehensive operational services, marketing support, and continued clinical research. When you purchase a system, you are making an important investment. NeuroStar provides the support to operationalize your system quickly and help you be successful. Meaning, you can be confident that your investment will pay off.

NeuroStar is designed from the ground up to deliver precise TMS within the rigor of a daily high-throughput clinical setting. It measures the precise dose, and monitors positioning for precise delivery.